First-in-human study of dual-imaging catheter to assess heart attack risk, guide treatment
Researchers at the UC Davis National Center for Interventional Biophotonic Technologies (NCIBT) have concluded the first-in-human test of a new device that could help doctors better detect and treat atherosclerosis, the narrowing of blood vessels due to plaque buildup. The flexible catheter-based de
<p>Researchers at the UC Davis National Center for Interventional Biophotonic Technologies (NCIBT) have concluded the first-in-human test of a new device that could help doctors better detect and treat atherosclerosis, the narrowing of blood vessels due to plaque buildup. The flexible catheter-based de</p>